• LAST PRICE
    4.7300
  • TODAY'S CHANGE (%)
    Trending Up0.0800 (1.7204%)
  • Bid / Lots
    4.7000/ 2
  • Ask / Lots
    5.3300/ 2
  • Open / Previous Close
    4.6200 / 4.6500
  • Day Range
    Low 4.6200
    High 4.8295
  • 52 Week Range
    Low 3.2300
    High 17.0000
  • Volume
    246,055
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 4.65
TimeVolumeMURA
09:32 ET182344.71
09:33 ET1004.71
09:42 ET5004.7
09:44 ET6004.68
09:48 ET14264.71
09:50 ET2004.725
09:51 ET3004.735
09:53 ET2004.735
09:55 ET4004.75
09:57 ET14344.7218
10:02 ET3504.7314
10:04 ET3004.76
10:06 ET2004.755
10:08 ET2004.755
10:09 ET5604.72
10:11 ET2004.71
10:13 ET2004.67
10:15 ET6004.67
10:18 ET18504.675
10:20 ET8004.67
10:22 ET1004.675
10:24 ET12004.69
10:26 ET3004.71
10:27 ET2004.695
10:29 ET6004.695
10:31 ET2004.69
10:36 ET5004.69
10:38 ET2004.69
10:42 ET4004.69
10:45 ET4624.69
10:49 ET2004.7
10:51 ET5004.715
10:54 ET25664.705
10:56 ET2004.705
10:58 ET7004.705
11:00 ET1004.705
11:02 ET4004.7
11:03 ET3004.7
11:05 ET6004.71
11:07 ET1004.7
11:09 ET2004.7
11:12 ET4004.7
11:14 ET36984.72
11:16 ET5004.72
11:18 ET4004.71
11:20 ET2004.705
11:21 ET23474.72
11:23 ET3004.72
11:25 ET3004.72
11:27 ET3004.72
11:30 ET2004.72
11:32 ET2004.72
11:34 ET4004.72
11:36 ET2004.72
11:38 ET46144.745
11:39 ET2004.745
11:43 ET2004.76
11:45 ET1004.745
11:48 ET2004.745
11:50 ET27534.71
11:52 ET2004.725
11:54 ET1004.71
11:56 ET10004.735
11:59 ET12004.74
12:01 ET2004.74
12:03 ET6004.74
12:06 ET12304.745
12:08 ET4004.745
12:12 ET13564.76
12:14 ET1874.75
12:15 ET1004.77
12:17 ET1004.76
12:19 ET2004.77
12:21 ET12014.78
12:24 ET7004.77
12:26 ET1004.775
12:28 ET7004.76
12:30 ET12484.75
12:32 ET2004.75
12:35 ET33394.77
12:37 ET1004.77
12:42 ET12004.819
12:46 ET1004.805
12:50 ET2004.805
12:53 ET11004.825
12:55 ET1004.825
12:57 ET4004.825
01:00 ET2504.8209
01:02 ET2004.825
01:04 ET3344.82
01:06 ET3004.7809
01:08 ET1004.7804
01:09 ET1004.76
01:11 ET5604.76
01:15 ET5004.775
01:22 ET2004.775
01:24 ET17004.76
01:26 ET1004.76
01:29 ET1004.775
01:31 ET1004.775
01:33 ET1004.775
01:36 ET14504.76
01:42 ET1004.775
01:44 ET3004.76
01:45 ET1004.775
01:47 ET1004.775
01:49 ET43234.79
01:51 ET4004.78
01:58 ET2004.76
02:03 ET1004.775
02:07 ET2074.775
02:09 ET2004.76
02:12 ET2004.775
02:14 ET3004.775
02:16 ET10004.75
02:20 ET7964.75
02:21 ET37104.76
02:25 ET4074.75
02:27 ET11004.755
02:30 ET6964.7501
02:32 ET8704.73
02:34 ET34004.71
02:36 ET2004.72
02:38 ET1004.71
02:39 ET2004.71
02:41 ET43534.75
02:43 ET75144.72
02:52 ET1004.72
02:54 ET42144.74
02:56 ET56524.755
02:57 ET4184.755
03:03 ET1004.755
03:08 ET27004.78
03:10 ET5684.77
03:14 ET2504.76
03:17 ET1004.75
03:19 ET27264.75
03:21 ET2004.76
03:24 ET1004.76
03:26 ET41524.79
03:28 ET28004.76
03:30 ET1004.76
03:33 ET2004.7406
03:37 ET4004.755
03:39 ET7004.75
03:42 ET2124.75
03:44 ET2004.75
03:46 ET4004.75
03:48 ET10634.73
03:50 ET31154.77
03:51 ET17974.75
03:53 ET11104.75
03:55 ET15404.75
03:57 ET71014.76
04:00 ET363124.73
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMURA
Mural Oncology PLC
77.6M
-0.4x
---
United StatesIMMX
Immix Biopharma Inc
76.9M
-3.3x
---
United StatesTIL
Instil Bio Inc
76.6M
-0.4x
---
United StatesLPTX
Leap Therapeutics Inc
76.4M
-0.5x
---
United StatesCRVO
CervoMed Inc
79.1M
-4.2x
---
United StatesALVR
Allovir Inc
80.0M
-0.4x
---
As of 2024-02-24

Company Information

Mural Oncology plc is a clinical-stage oncology company. The Company is leveraging its protein engineering platform to develop cytokine-based immunotherapies for the treatment of cancer. It leverages its expertise in cytokine biology, immune cell modulation and protein engineering capabilities to develop immunotherapies. The Company is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers, particularly those with limited treatment options available. Its portfolio of programs includes Nemvaleukin alfa (Nemvaleukin)-IL-2, IL-12, and IL-18. Nemvaleukin is an engineered interleukin-2 (IL-2) variant designed to harness the potent anti-cancer capabilities of high-dose rhIL-2 while minimizing toxicity by selectively activating cancer-fighting CD8 T cells and NK cells. The tumor-targeted split IL-12 program focuses on delivering the therapeutic potential of IL-12 by splitting it into inactive component.

Contact Information

Headquarters
10 Earlsfort TerraceDUBLIN, Ireland D02 T380
Phone
---
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$77.6M
Revenue (TTM)
$0.00
Shares Outstanding
16.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-11.77
Book Value
$-1.30
P/E Ratio
-0.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.